.
  • NIFTY 25,891.40 +22.80 (+0.09%)
  • SENSEX 84,556.40 +130.06 (+0.15%)
BSE
NSE

Thursday, October 23, 2025 , BSE Sensex : 84,556.40 84,556.40(0.15%) , Adani Ports : 1,452.45 1,452.45(-1.41%) , Asian Paints : 2,501.85 2,501.85(-0.26%) , Axis Bank : 1,259.40 1,259.40(1.90%) , Bajaj Finance : 1,094.20 1,094.20(0.69%) , Bajaj Finserv : 2,175.85 2,175.85(0.28%) , Bharat Electron : 418.50 418.50(0.22%) , Bharti Airtel : 2,008.35 2,008.35(-1.71%) , Eternal Ltd : 328.30 328.30(-2.88%) , HCL Technologies : 1,524.05 1,524.05(2.43%) , HDFC Bank : 1,008.95 1,008.95(0.16%) , Hind. Unilever : 2,600.75 2,600.75(0.33%) , ICICI Bank : 1,363.50 1,363.50(-1.35%) , Infosys : 1,528.85 1,528.85(3.86%) , ITC : 415.85 415.85(0.73%) , Kotak Mah. Bank : 2,225.05 2,225.05(1.32%) , Larsen & Toubro : 3,918.00 3,918.00(0.79%) , M & M : 3,622.70 3,622.70(0.08%) , Maruti Suzuki : 16,383.30 16,383.30(-0.04%) , NTPC : 342.60 342.60(0.15%) , Power Grid Corpn : 289.65 289.65(0.31%) , Reliance Industr : 1,448.05 1,448.05(-1.17%) , SBI : 911.45 911.45(0.37%) , Sun Pharma.Inds. : 1,689.00 1,689.00(-0.08%) , Tata Motors : 405.85 405.85(0.98%) , Tata Steel : 174.10 174.10(0.75%) , TCS : 3,074.65 3,074.65(2.24%) , Tech Mahindra : 1,462.85 1,462.85(1.00%) , Titan Company : 3,771.85 3,771.85(1.15%) , Trent : 4,784.35 4,784.35(-0.12%) , UltraTech Cem. : 12,142.75 12,142.75(-1.65%) ,

Nifty 50 : 25,891.40 22.80(0.09%) , Adani Enterp. : 2,545.80 -4.10(-0.16%) , Adani Ports : 1,453.10 -20.40(-1.38%) , Apollo Hospitals : 7,968.50 -43.50(-0.54%) , Asian Paints : 2,502.40 -2.20(-0.09%) , Axis Bank : 1,258.80 21.50(1.74%) , Bajaj Auto : 9,047.00 -71.00(-0.78%) , Bajaj Finance : 1,094.15 7.65(0.70%) , Bajaj Finserv : 2,176.60 7.50(0.35%) , Bharat Electron : 418.65 0.95(0.23%) , Bharti Airtel : 2,007.90 -35.60(-1.74%) , Cipla : 1,645.10 -18.50(-1.11%) , Coal India : 392.65 1.55(0.40%) , Dr Reddy's Labs : 1,279.40 -9.30(-0.72%) , Eicher Motors : 6,884.50 -134.00(-1.91%) , Eternal Ltd : 328.35 -9.75(-2.88%) , Grasim Inds : 2,864.60 -6.10(-0.21%) , HCL Technologies : 1,523.90 37.90(2.55%) , HDFC Bank : 1,008.80 1.10(0.11%) , HDFC Life Insur. : 743.65 -0.05(-0.01%) , Hind. Unilever : 2,601.60 9.90(0.38%) , Hindalco Inds. : 792.40 7.45(0.95%) , ICICI Bank : 1,363.70 -18.30(-1.32%) , Infosys : 1,528.50 56.10(3.81%) , Interglobe Aviat : 5,789.00 -124.00(-2.10%) , ITC : 415.95 3.10(0.75%) , Jio Financial : 309.05 -2.75(-0.88%) , JSW Steel : 1,138.20 -14.30(-1.24%) , Kotak Mah. Bank : 2,225.60 28.60(1.30%) , Larsen & Toubro : 3,918.70 30.50(0.78%) , M & M : 3,623.60 2.40(0.07%) , Maruti Suzuki : 16,393.00 -3.00(-0.02%) , Max Healthcare : 1,211.00 7.00(0.58%) , Nestle India : 1,272.80 -14.50(-1.13%) , NTPC : 342.65 0.65(0.19%) , O N G C : 252.31 4.19(1.69%) , Power Grid Corpn : 289.65 1.05(0.36%) , Reliance Industr : 1,448.40 -16.80(-1.15%) , SBI : 911.55 3.70(0.41%) , SBI Life Insuran : 1,852.70 11.70(0.64%) , Shriram Finance : 709.65 14.40(2.07%) , Sun Pharma.Inds. : 1,689.90 -0.60(-0.04%) , Tata Consumer : 1,161.00 -13.60(-1.16%) , Tata Steel : 174.16 1.38(0.80%) , TCS : 3,073.20 66.50(2.21%) , Tech Mahindra : 1,463.40 14.70(1.01%) , Titan Company : 3,772.30 43.30(1.16%) , Trent : 4,783.30 -7.80(-0.16%) , UltraTech Cem. : 12,145.00 -197.00(-1.60%) , Wipro : 244.30 2.94(1.22%) , Thursday, October 23, 2025

Home >> Markets >> Equities >> News - News Details
Corporate News
16-Oct-2025     16:28
Biocon Biologics expands its strategic collaboration with Civica

Biocon Biologics, a subsidiary of Biocon, announced expansion of its strategic collaboration with Civica, Inc. (Civica) to include a new Insulin Glargine medicine that will benefit patients in the United States by increasing supply of high-quality affordable insulins.

The multi-year transformational agreement between Biocon Biologics and Civica creates an exclusive distributorship arrangement where Biocon Biologics will manufacture and supply Insulin Glargine medicine to Civica, and Civica will commercialize under Biocon Biologics' existing marketing approval (a private label agreement). Civica will distribute, promote, and sell the medicine in the United States under a separate Civica label and trade dress, and in California, the product will carry the CalRx brand. Biocon Biologics will continue to directly commercialize Biocon Biologics' own Insulin Glargine-yfgn medicine, which was approved by the U.S. Food and Drug Administration (FDA) in July 2021 as the first interchangeable biosimilar.

No technology transfer is involved in the agreement and Biocon Biologics will continue to own the intellectual property and marketing authorization associated with Insulin Glargine. Additional terms of the agreement are not disclosed.

Powered by Capital Market - Live News